Particle Count Or Volume Standard Or Control (e.g., Platelet Count Standards, Etc.) Patents (Class 436/10)
  • Patent number: 4528274
    Abstract: A method and reagent system is described for differential determination of more that one class of leukocyte populations, using an automatic blood cell analyzer. The reagent system includes a blood diluent and stromatolyzing reagent. The blood diluent is an osmotically balanced aqueous solution of ingredients for maintaining erythrocyte morphology, blood cell stabilizing, buffering and bacteriostatic action. The stromatolyzing reagent is a mixture of an aqueous solution of quaternary ammonium salts, a chromagen forming agent and an additive which is a non-cationic surfactant. The quaternary ammonium salts, with the additive, serve the purpose of positioning, relative to one another and a volume reference point, the lymphoid and myeloid populations. The additive also acts to prevent or to reduce the amount of protein deposit in the sensing orifices of the analyzer, which deposit tends to accumulate from the cell debris resulting from blood cell stromatolyzation.
    Type: Grant
    Filed: March 25, 1983
    Date of Patent: July 9, 1985
    Assignee: Coulter Electronics, Inc.
    Inventors: James H. Carter, Stephen L. Ledis, Harold R. Crews, Ted Sena, Fred L. Larsen
  • Patent number: 4521518
    Abstract: An isotonic multipurpose blood diluent, and a method for use of this diluent with a weak lysing reagent system which is especially suitable for routine enumeration of traditional hemogram values, and also the determination of lymphoid-myeloid populations of leukocytes, particularly in automatic particle counting systems.This blood diluent is capable of affording accurate, reproducible test results. It is an osmotically balanced aqueous solution of preselected pH containing Procaine hydrochloride for maintaining erythrocyte morphology during operation, N-(2-acetamido)iminodiacetic acid (ADA) as a blood cell stabilizing agent, and bacteriostatic agents including sodium 1-hydroxypyridine-2-thione, and dimethylolurea which, together with the ADA, allow preferential determination of myeloid-lymphoid leukocytes, and other hematological values.The lysing agent is a mixture of an aqueous solution of at least one quaternary ammonium salt having surface active properties, and an alkali metal cyanide.
    Type: Grant
    Filed: July 6, 1982
    Date of Patent: June 4, 1985
    Assignee: Coulter Electronics, Inc.
    Inventors: James H. Carter, Stephen L. Ledis, Harold R. Crews
  • Patent number: 4510126
    Abstract: An agent for determining ristocetin cofactor (v.Willebrand factor) is described, which contains platelets which have been treated with a tanning agent, with a protease inhibitor and, optionally, with a dye-stuff, and ristocetin A.
    Type: Grant
    Filed: September 30, 1982
    Date of Patent: April 9, 1985
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Peter Fuhge, Konrad Braun, Udo Becker
  • Patent number: 4506018
    Abstract: An improved multi-purpose blood diluent is provided which is isotonic, with a neutral pH for avoiding cell volume change. The diluent of the invention provides balance between the effects on cell volume of a preservative for the solution, and the effects of a surfactant. The diluent of the invention is particularly useful as a carrier for blood samples in instruments which automatically provide medical diagnostic determinations of blood samples. The diluent herein includes conventional sodium and potassium chlorides as electrolytes, pH buffers, such as monobasic and dibasic phosphate, and ethylene diamine tetraacetic acid to control and chelate the divalent cations. The balanced preservative-surfactant combination may include, for example, 2-phenoxyethanol with certain ethylene oxide-polypropylene glycol condensation products.
    Type: Grant
    Filed: December 30, 1982
    Date of Patent: March 19, 1985
    Assignee: Becton, Dickinson and Company
    Inventor: Howard L. North, Jr.
  • Patent number: 4489162
    Abstract: Hematologic control and calibration standards are disclosed which are essentially plasma-free. These controls are prepared by the suspension of red blood cells in an appropriate buffer containing a stabilization effective amount of disaccharides, and other optional ingredients. Control and calibration standards prepared in the foregoing manner are suitable in the control and calibration of hematology analyzers for the following parameters: white cell count, red cell count, hemoglobin, hematocrit and the common derived parameters (i.e., mean cell volume, mean cell hemoglobin and mean cell hemoglobin concentration). The addition of platelets to the foregoing suspensions is also contemplated to provide a control for platelet parameters.
    Type: Grant
    Filed: December 21, 1981
    Date of Patent: December 18, 1984
    Assignee: American Hospital Supply Corporation
    Inventors: Pamela L. Hawkins, Carole J. Young
  • Patent number: 4485175
    Abstract: A method and reagent system is described for differential determination of three-populations of leukocytes (lymphocyte, monocyte and granulocyte), using an automatic counting system. The reagent system includes a blood diluent and lysing reagent. The blood diluent is an osmotically balanced aqueous solution of ingredients at a preselected pH for maintaining erythrocyte morphology, blood cell stabilizing, buffering and bacteriostatic action. The lysing reagent is a mixture of an aqueous solution of quaternary ammonium salts, which lysing reagent is added to the diluted blood under more mild conditions of concentration and at a slower rate than is current practice in order to obtain an unexpected volumetric modification of at least one of the three-populations of leukocytes, whereby volumetric differential analysis can be accomplished.
    Type: Grant
    Filed: January 3, 1983
    Date of Patent: November 27, 1984
    Assignee: Coulter Electronics, Inc.
    Inventors: Stephen L. Ledis, Ted Sena, Harold R. Crews, James H. Carter, II
  • Patent number: 4436821
    Abstract: A lysable, blood platelet reference control comprising a suspension of a mixture of permanently shrunken animal red blood cells in a suspension medium non-deleterious to said cells, said cells having been partially fixed with a fixing agent to reduce cell membrane elasticity prior to being shrunken, and said mixture of permanently shrunken cells in said suspension medium simulating in number, size and volume distribution the platelets present in human whole blood.
    Type: Grant
    Filed: April 12, 1982
    Date of Patent: March 13, 1984
    Assignee: Streck Laboratories, Inc.
    Inventor: Wayne L. Ryan
  • Patent number: 4412004
    Abstract: A method is disclosed of blood serum sample preparation for improved, more accurate and precise, electro-optical method for measuring erythrocyte volumes, individually and as an average.
    Type: Grant
    Filed: June 26, 1981
    Date of Patent: October 25, 1983
    Assignee: Technicon Instruments Corporation
    Inventors: Leonard Ornstein, Young R. Kim
  • Patent number: 4405719
    Abstract: This invention utilizes for stabilization of platelets a combination of iodoacetamide and an iminodiacetic acid or salt thereof, together with a compatible bacteriostatic agent, in an aqueous electrolytic solution which is maintained at a preselected range of pH and osmolality.In a preferred formulation, the stabilizing solution contains iodoacetamide, N-(2-acetamido)iminodiacetic acid and sodium penicillin. Ethylenediaminetetraacetic acid, or salts thereof, are optionally present as an additional ingredient.
    Type: Grant
    Filed: May 29, 1981
    Date of Patent: September 20, 1983
    Assignee: Coulter Electronics, Inc.
    Inventors: Harold R. Crews, James H. Carter, II, Ted Sena
  • Patent number: 4390632
    Abstract: Biological cell compositions are stabilized to preserve aldehyde functionality by formation of acetal, particularly cyclic acetal, primarily in order to prevent cell-to-cell crosslinking. The stabilized biological cells are particularly useful as human blood particle analogs in reference reagents employed in electronic hematology testing instrumentation.A process for preparing the acetal-stabilized biological cells employs reaction of polyaldehyde-treated biological cells with alcohol, preferably including 1,2 dialcohol, under acidic conditions; thereafter, the resulting product solution is adjusted to basic condition, stabilizing the acetal formation on the biological cells.
    Type: Grant
    Filed: July 14, 1980
    Date of Patent: June 28, 1983
    Assignee: Coulter Electronics, Inc.
    Inventor: James H. Carter, II
  • Patent number: 4389490
    Abstract: Stabilized reference control and calibrator compositions for determining multiple platelet parameters in stand alone platelet controls and whole blood reference controls are prepared from platelets stabilized with a fixative-stabilizing composition containing glutaraldehyde and a non-ionic surfactant which is a mixture of ethoxylates of certain isomeric linear alcohols.
    Type: Grant
    Filed: May 29, 1981
    Date of Patent: June 21, 1983
    Assignee: Coulter Electronics, Inc.
    Inventors: Harold R. Crews, James H. Carter, II, Ted Sena